US Stock MarketDetailed Quotes

MXCT MaxCyte

Watchlist
  • 4.118
  • -0.072-1.72%
Trading Dec 19 10:12 ET
434.39MMarket Cap-12.11P/E (TTM)

MaxCyte Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

MaxCyte Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
7.36M
8.16M
+799.67K
Beat Est.
-8.00%
+2.00%
+10.86%
EPS
-0.12
-0.11
+0.01
Beat Est.
-12.10%
--
+10.71%
Analyst Rating
Strong Buy

Dec 19, 2024

MaxCyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 9.329M--
--2024/Q4-- / 7.667M--
Nov 6, 20242024/Q38.164M / 7.364M--
Aug 6, 20242024/Q210.429M / 7.933M--
May 7, 20242024/Q111.342M / 7.441M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 9.329M--
--2024/Q4-- / 7.667M--
Nov 6, 20242024/Q38.164M / 7.364M--
Aug 6, 20242024/Q210.429M / 7.933M--
May 7, 20242024/Q111.342M / 7.441M--

Unlock Free Earnings Estimates

MaxCyte Earnings Reports

  • MaxCyte | 10-Q: Quarterly report

    Nov 6 16:57 ET

  • MaxCyte | 8-K: MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

    Nov 6 16:27 ET

  • MaxCyte | 10-Q: Quarterly report

    Aug 6 16:59 ET

  • MaxCyte | 8-K: MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance

    Aug 6 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 19, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data